J Immunol Meth. = 0048 by Student’s = 16)= 45)= 13)= 20)(XL1 blue MRF’) and phage vector, diluted pool was preadsorbed three times on nonrecombinant phage plaques. For main immunoscreening the library was plated out at 12500 pfu/140 mm plate using XL1 blue MRF’ sponsor cells according to the supplier’s instructions. In brief, nitrocellulose filters were incubated with 10 mm isopropyl-D-thiogalacto-pyranoside (IPTG) for 20 min and air-dried. Filters were then overlaid O6BTG-octylglucoside onto the plates and incubated for 4 h at 37C. After incubation, their orientation was designated and they were cautiously eliminated, and clogged for 1 h in 5% milk/PBS. A preadsorbed pool of sera was then added to the filters and incubated over night at RT with mild agitation. Membranes were then washed four occasions with 005% PBS Tween-20 O6BTG-octylglucoside over 15 min. Bound antibody was recognized using 1 : 3000 dilution of mouse anti-human IgG (Bio-Rad, Richmond, CA, USA) in PBS comprising 005% Tween-20, 1% milk for 3 h at RT. After a final four washes in 005% PTGS2 PBS Tween-20 membranes were incubated for 20 min with diaminobenzidine substrate (Sigma Aldrich, St. Louis, MO, USA). Plaques related to immunoreactive areas were cored from the original plate and resuspended in suspension medium (SM) comprising 10 l chloroform. Positive plaques were re-screened with the same pool of sera to obtain the clonality. Cloned phage showing immunoreactivity was recovered as pBluescript by single-stranded save using the helper phage (Stratagene) according to the supplier’s instructions and used to transform SolR XL1cells. Positive recombinants were then harvested and produced over night in 5 ml LB and plasmid DNA isolated using the Qiagen Plasmid Mini Kit (Qiagen, GmbH, Hilden, Germany). The nucleotide sequence of the cloned cDNA insertion was sequenced with automated sequencer ABI Prism 310 Collection (Applied Biosystems, Foster City, CA, USA) and sequences were then compared with the GenBank sequence database using both Fasta and Blast analysis [23,24]. Indirect immunofluorescence assay Human being umbilical vein endothelial cells (HUVEC) were isolated by collagenase perfusion from normal-term umbilical wire veins, as previously described [25], and cultured in M-199 medium (Sigma) supplemented with 20% fetal calf serum (FCS), 2 mm l-glutamine (Bio Whittaker, Verviers, Belgium), 100 U/ml penicillin, 100 mg/ml streptomycin at 37C inside a humidified atmosphere of 5% CO2. HUVEC, produced to 60C70% confluency, seminated at 5 106 per well on glass coverslips, were fixed with acetone/methanol 1/1 (v/v) for 10 min at 4C and then soaked in balanced salt answer (BSS) (Sigma) for 30 min at 25C. Cells were then incubated for 30 min at 25C in the obstructing buffer (2% bovine serum albumin (BSA) in PBS, comprising 5% glycerol and 02% Tween-20). Cells were then labelled with rabbit anti-actin polyclonal antibodies (Sigma) or with sera from healthy donors or individuals with atherosclerosis and were incubated for 1 h at 4C. After washing three times O6BTG-octylglucoside with PBS, cells were incubated with fluorescein isothiocyanate (FITC)-conjugated goat polyclonal anti-rabbit IgG or with FITC-conjugated anti-human IgG in PBS 1% BSA, for 30 min at 4C. The fluorescence distribution was analysed having a fluorescence microscope Olympus U RFL T equipped with RT Spot power supply (Diagnostic Devices Inc., MI, USA). ELISA ELISA for specific total IgG was developed essentially as explained by Challacombe conditions. The mean OD ideals for IgG immunoreactivity were significantly higher in individuals with carotid atherosclerosis and in individuals with SLE than in the healthy control group (059 016 and 076 030 046 015; < 10?4, by Student's 076 030; = 0001). The rate of recurrence of actin-specific IgG O6BTG-octylglucoside was significantly higher in individuals than in healthy subjects (atherosclerosis, 16/61 26% and SLE, 13/33, 39%2/41, 5%, = 0012 and < 10?4 by 2 test); and in individuals with SLE than in individuals with diabetes type 1 (13/33, 39%2/26, 76%; = 001) (Fig. 3). IgG subclass analysis in the 16 individuals with carotid atherosclerosis showed the presence of anti-actin IgG1 and IgG2 isotypes: 5 individuals (31%) experienced anti-actin IgG1; 5 (31%) experienced IgG2; and 6 (37%) experienced IgG1 and IgG2. All the 13 individuals with SLE experienced anti-actin IgG1 and IgG2. Open in a separate windows Fig. 2 Anti-actin reactivity in individuals with carotid atherosclerosis, systemic lupus erythematosus (SLE), type 1 diabetes and in healthy subjects. Each dot represents a subject. The dotted collection represents the average value plus two standard deviations of the.